Byrne Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Byrne Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$4.08K	–	614
2025 Q3	$4.08K	Buy	+500	New	+$4.08K	﹤0.01%	490

Byrne Asset Management's ARRY Position: Q4 2025 in Review

Byrne Asset Management sold out of Array Biopharma Inc (ARRY) in Q4 2025, closing a stake of 500 shares — an estimated $4.08K sold.

Byrne Asset Management first reported a position in ARRY in Q3 2025 and held it in 1 quarter. The position peaked at $4.08K in Q3 2025. 0 funds tracked by Wall St. Rank hold ARRY as of Q4 2025.

Byrne Asset Management reported no remaining Array Biopharma Inc position as of Q4 2025 after selling out during the quarter.
Byrne Asset Management sold 500 Array Biopharma Inc shares in Q4 2025, an estimated $4.08K.
Byrne Asset Management first reported a position in Array Biopharma Inc in Q3 2025 and held it in 1 quarter.
Byrne Asset Management's Array Biopharma Inc position peaked at $4.08K in Q3 2025.
0 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2025.

Based on Byrne Asset Management's 13F filing for Q4 2025, filed 12 Jan 2026.